Sue Gail Eckhardt Exelixis, Inc. (EXEL) insider trading activity

Sue Gail Eckhardt is Director of EXELIXIS, INC.. Currently has a direct ownership of 34,262 shares of EXEL, which is worth approximately $905,887. The most recent transaction as insider was on May 31, 2024, when has been sold 18,838 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.3K

0% 3M change

n/a 12M change

Total Value Held $905,887

Sue Gail Eckhardt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 31 2024	BUY Grant, award, or other acquisition	-	18,838 Added 35.48%	34,262 Common Stock
Jan 05 2024	BUY Grant, award, or other acquisition	-	15,424 Added 50.0%	15,424 Common Stock

Also insider at

SYRS

Syros Pharmaceuticals, Inc. Healthcare

SGE